Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Dr. Meritxell Genescà gets a grant from the Dexeus Women's Health Foundation

The goal of this project is to characterize the reservoirs of dormant HIV in cervical tissue and study new strategies to eliminate them.

News

VHIR signs an agreement with ALUDME for the research of Mycelonic Dystonia

The Association of the fight against the DIstonia, ALUDME, and Vall d'Hebron decide to work together in order to raise funds destined for the investigation of Mycological Classics, a minority illness that affects mainly children.

News

Researchers of the Vall d'Hebron Campus participate in the seminar Al càncer donem-li recerca!

On February 15, on the occasion of the International Day of Childhood Cancer, patients, students and the public will interact with the experts through workshops and debates at the CosmoCaixa in Barcelona.

News

Dr. Marc Miravitlles leads the official European guide to pulmonary disease due to alpha-1 antitrypsin deficit

Among the novelties of the guide, it stands out that it is established which people have to make determinations to diagnose the disease.

News

A new strategy demonstrates its potential in the treatment of Parkinson's Disease in mice

Although research on this treatment is still in preclinical phase, researchers emphasize how these new therapeutic strategies could slow the progression of the symptoms of Parkinson's Disease.

News

The MAGBBRIS european project, coordinated by Dr. Anna Rosell, receives funding from the Instituto de Salud Carlos III, in the framework of the EuroNanoMed III call

We want is to be more efficient in therapeutic product release to the brain, reaching the specific areas of neuroerpair with a sustained release over time time through a nanocapsule.

News

2nd Meeting of the Business Council of VHIR

Chaired by Lluís Bassat, the Council is made up of 15 outstanding representatives of the economic, business and biotechnology world who advise the Management and the Board of the Institute.

News

Fourth call of the PhD4MD biomedical research training programme for medical doctors

There are currently eight medical doctors conducting research in centres of excellence in Barcelona, among them Dr. Alberto Indacochea, at VHIR, and this year this number may increase by up to four more.

News

Scientists emulate the human blood–retinal barrier on a microfluidic chip

It ontains living cells and mimics the structure and physiological conditions of the blood-retinal barrier. Enables to test molecules in vitro and to study diseases such as diabetic retinopathy.

News

Vall d'Hebron provides the first patient of an international trial with the drug MIN-102 for adrenomyeloneuropathy

ADVANCE study is to recruit more than 100 patients to confirm the efficacy and safety of this drug against the adrenomyeloneuropathy.

News

Bufa la bombolla donates more than 7,000 euros for the PID Foundation

Bufa la bombolla is an initiative of the parents of a girl with a primary immunodeficiency to raise funds for research into these diseases.

News

Virtual reality improves treatment of patients with attention-deficit/hyperactivity disorder

From a year ago, Vall d'Hebron offers treatment with virtual reality to patients who suffer from it in the context of a randomized and controlled study.

News

Andrés Iniesta has visited the Neonatology Service of Vall d'Hebron to support the campaign “Amb tu, com a casa”

Accompanied by his wife, they have been able to see first hand about the needs of hospitalized babies and their parents and support the campaign "Amb tu, com a casa", of which they are sponsors.

News

Two VHIR projects receive a Gilead Fellowships for Biomedical Research

Dr. Francisco Rodríguez Frias, for hepatitis C research, and Dr. María José Buzón, for research in HIV, has been awarded a Gilead Fellowships worth 50,000 euros.

News

The Area of Functional Validation & Preclinical Research of CIBBIM-Nanomedicine obtains the ISO 9001:2008 certification of Quality Management System

The Functional Validation & Preclinical Research (FVPR), led by Dr. Ibane Abasolo, was created in 2007 as part of the CIBBIM-Nanomedicine's technological offer.

News

A Vall d'Hebron study shows underuse of lung transplantation in patients with pulmonary arterial hypertension

Out of the 1,391 patients included in the study, led by Dr. Manuel López-Meseguer, only 36 underwent lung transplant.

News

Neurologists of the Vall d'Hebron Stroke Unit design a protocol that considerably improves the detection of one of the main causes of severe stroke

Thanks to the proposed new protocol paroxysmal atrial fibrillation is detected in up to 20% of patients.

News

RSNA Travel Award for research into the anticipation of the development of malignant lesions in patients with neurofibromatosis through diagnostic imaging

The combination between magnetic resonance and PET-CT is essential to diagnose, determine the extent and monitor the evolution towards more malignant forms of multiple neurofibromas.

News

A pioneering study led by Dr. Amparo Santamaría will determine the cause and effect relationship between genetic thrombophilia and fertility problems

The pioneering study WiTEAM 2018-2020 (Women International Team) led by Dr. Amparo Santamaría, will determine the cause and effect relationship between genetic thrombophilia and reproductive problems in women.

News

Proven the use of the polyurethane nanoparticle and poliurea (PUUa) for the improvement of therapy against cancer

Easy and specific: PUUa nanoparticles show great potential in cancer therapy.